Brain Interrupted-Early Life Traumatic Brain Injury and Addiction Vulnerability - ohsw
Tracking # 20-984046
$99999.00
There are no ratings for this course
Learn moreCourse overview
This research intensive course focuses on early-life Traumatic Brain Injury (TBI) and Substance Use Disorder (SUDD). It includes: animal models of addiction, TBI and the young brain, clinical and epidemiological data on early-life TBI, preclinical studies (animal models of TBI), development and maturation of the reward pathway, TBI neuropathology and neuroinflammation in the addiction pathway, anatomical alterations following TBI in the maturing brain, induction of inflammatory markers, blood-brain barrier hyper-permeability, synaptic alterations, changes to the dopaminergic system, TBI and addiction, Clinical history of TBI and susceptibility to SUD, preclinical evidence of SUD risk following early-life TBI, the possible mechanistic role of Orexin in TBI and SUD, and confounding variables of TBI-related SUD. This course is neuroscience intensive. This course is based on the reading-based online, Brain interrupted-Early life traumatic brain injury and addiction vulnerability created by Lee Anne Cannella and Hannah McGary in 2019.
Subject areas
This course counts toward the state boards and subject areas below.
Ohio Counselor, Social Worker and Marriage and Family Therapist Board
Licensed Independent Marriage and Family Therapist
Licensed Independent Social Worker
Licensed Social Worker
Marriage and Family Therapist
Registered Social Worker Assistant
Disclosure statements
##### Disclosure of Relevant Financial Relationships
CE Learning Systems, LLC is an independent provider of continuing medical education. CE Learning Systems, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, CE Learning Systems, LLC is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest).
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and
- - any investigational, off-label, or non-FDA approved content or discussion
- CE Learning Systems, LLC has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
- Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:
- - All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- - All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- - Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
- ##### Planners
- The planners have reported the following: There are no relevant disclosures.
- ##### Course Material Authors
- The authors have disclosed any disclosures within the material.
- ##### Course Creator: L.A. Rankin
- There are no relevant disclosures.
- ##### Commercial support
- There is no commercial support for this distance-learning course.